{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T02:08:45Z","timestamp":1777774125551,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/INF\/22\/SP41176\/2020"],"award-info":[{"award-number":["BT\/INF\/22\/SP41176\/2020"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007741","name":"University of Hyderabad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007741","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ijbiomac.2025.150012","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:35:31Z","timestamp":1767339331000},"page":"150012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Targeting mycobacterial PPE65 protein to develop a multi-epitope vaccine candidate against tuberculosis"],"prefix":"10.1016","volume":"340","author":[{"given":"Monalisa","family":"Swargiary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahila","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Jyotisha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7720-7067","authenticated-orcid":false,"given":"Insaf Ahmed","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.150012_bb0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13244-022-01172-0","article-title":"Extrapulmonary tuberculos\u0131s: an old but resurgent problem","volume":"13","author":"Baykan","year":"2022","journal-title":"Insights Imaging"},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0010","series-title":"Global Tuberculosis Report 2024","author":"World Health Organization","year":"2024"},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0015","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2013.070","article-title":"The biology of Mycobacterium tuberculosis infection","volume":"5","author":"Delogu","year":"2013","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023360","article-title":"A booster vaccine expressing a latency-associated antigen augments BCG induced immunity and confers enhanced protection against tuberculosis","volume":"6","author":"Dey","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0025","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrmicro1419","article-title":"Advances in tuberculosis vaccine strategies","volume":"4","author":"Skeiky","year":"2006","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0030","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa1909953","article-title":"Final analysis of a trial of M72\/AS01E vaccine to prevent tuberculosis","volume":"381","author":"Tait","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0035","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3389\/fimmu.2017.01147","article-title":"The recombinant Bacille Calmette-Gu\u00e9rin vaccine VPM1002: ready for clinical efficacy testing","volume":"8","author":"Nieuwenhuizen","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.935444","article-title":"Therapeutic efficacy against Mycobacterium tuberculosis using ID93 and liposomal adjuvant formulations","volume":"13","author":"Baldwin","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0045","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s40121-023-00806-0","article-title":"Safety and immunogenicity of the ID93+ GLA-SE tuberculosis vaccine in BCG-vaccinated healthy adults: a randomized, double-blind, placebo-controlled phase 2 trial","volume":"12","author":"Choi","year":"2023","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0050","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S1473-3099(23)00514-5","article-title":"Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control","volume":"24","author":"Gong","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0055","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s10989-020-10140-5","article-title":"Designing of nucleocapsid protein based novel multi-epitope vaccine against SARS-CoV-2 using immunoinformatics approach","volume":"27","author":"Kumar","year":"2021","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1497580","article-title":"Multi-epitope vaccines: a promising strategy against viral diseases in swine","volume":"14","author":"Chen","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0065","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/IAI.68.2.791-795.2000","article-title":"ESAT-6 subunit vaccination against Mycobacterium tuberculosis","volume":"68","author":"Brandt","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0070","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1128\/IAI.00024-08","article-title":"Vaccine-elicited 10-kilodalton culture filtrate protein-specific CD8+ T cells are sufficient to mediate protection against Mycobacterium tuberculosis infection","volume":"76","author":"Wu","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0075","article-title":"A subunit vaccine Ag85A-LpqH focusing on humoral immunity provides substantial protection against tuberculosis in mice","volume":"28","author":"Zeng","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0080","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-3083.2009.02325.x","article-title":"New alternative vaccine component against Mycobacterium tuberculosis \u2013 heat shock protein 16.3 or its T-cell epitope","volume":"70","author":"Shi","year":"2009","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0085","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/497203","article-title":"Mycobacterial PE\/PPE proteins at the host\u2013pathogen interface","volume":"2011","author":"Sampson","year":"2011","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0090","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1038\/s41598-024-84667-8","article-title":"Strong immune responses and robust protection following a novel protein in adjuvant tuberculosis vaccine candidate","volume":"15","author":"Korompis","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0095","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1073\/pnas.0712077106","article-title":"Defined tuberculosis vaccine, Mtb72F\/AS02A, evidence of protection in cynomolgus monkeys","volume":"106","author":"Reed","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0100","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-3083.2012.02726.x","article-title":"Novel recombinant BCG coexpressing Ag85B, ESAT-6 and Rv2608 elicits significantly enhanced cellular immune and antibody responses in C57BL\/6 mice","volume":"76","author":"Lu","year":"2012","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/08853282221079105","article-title":"Chitosan nanoparticles containing fusion protein (Hspx-PPE44-EsxV) and resiquimod adjuvant (HPERC) as a novel booster vaccine for Mycobacterium tuberculosis","volume":"37","author":"Hoseinpur","year":"2022","journal-title":"J. Biomater. Appl."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0110","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1348-0421.2008.00029.x","article-title":"PPE protein (Rv3425) from DNA segment RD11 of Mycobacterium tuberculosis: a novel immunodominant antigen of Mycobacterium tuberculosis induces humoral and cellular immune responses in mice","volume":"52","author":"Wang","year":"2008","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0115","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1128\/CVI.05708-11","article-title":"Serodiagnosis efficacy and immunogenicity of the fusion protein of Mycobacterium tuberculosis composed of the 10-kilodalton culture filtrate protein, ESAT-6, and the extracellular domain fragment of PPE68","volume":"19","author":"Xu","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0120","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3389\/fmicb.2016.00719","article-title":"Mycobacterium tuberculosis co-operonic PE32\/PPE65 proteins alter host immune responses by hampering Th1 response","volume":"7","author":"Khubaib","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0125","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bbrc.2018.11.094","article-title":"PPE65 of M. tuberculosis regulates pro-inflammatory signalling through LRR domains of Toll-like receptor-2","volume":"508","author":"Qureshi","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0130","series-title":"Immunoinformatics Prediction of Epitope-based Peptide Vaccine Against Mycobacterium tuberculosis PPE65 Family Protein","volume":"755983","author":"Elhag","year":"2019"},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0135","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s10989-023-10535-0","article-title":"Advances in computational and bioinformatics tools and databases for designing and developing a multi-epitope-based peptide vaccine","volume":"29","author":"Shawan","year":"2023","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0140","doi-asserted-by":"crossref","first-page":"11225","DOI":"10.1021\/ja9621760","article-title":"Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids","volume":"118","author":"Jorgensen","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.135105","article-title":"Discovery of 8-hydroxy-2-quinoline carbaldehyde derivatives as inhibitors for M1 aminopeptidase of Leishmania donovani","volume":"279","author":"Kumar","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.141820","article-title":"Exploration of membrane-bound ecto-phosphatase to identify potential therapeutic target for leishmaniasis","volume":"307","author":"Jyotisha","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-3233(08)60063-7","article-title":"Turns in peptides and proteins","volume":"37","author":"Rose","year":"1985","journal-title":"Adv. Protein Chem."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0165","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/854507","article-title":"Th1 and Th17 cells in tuberculosis: protection, pathology, and biomarkers","volume":"2015","author":"Lyadova","year":"2015","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0170","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1600-065X.2010.00978.x","article-title":"Use of defined TLR ligands as adjuvants within human vaccines","volume":"239","author":"Duthie","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1383098","article-title":"The role of ESAT-6 in tuberculosis immunopathology","volume":"15","author":"Passos","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0180","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0264-410X(02)00566-2","article-title":"Two years into reverse vaccinology","volume":"21","author":"Adu-Bobie","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0185","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.virol.2010.12.016","article-title":"Contributions of humoral and cellular immunity to vaccine-induced protection in humans","volume":"411","author":"Amanna","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0190","article-title":"UB-612 pan-SARS-CoV-2 T cell immunity-promoting vaccine protects against COVID-19 moderate-severe disease","volume":"27","author":"Wang","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1280299","article-title":"Design and immunoinformatic evaluation of a multi-epitope vaccine candidate PP13138R against Mycobacterium tuberculosis","volume":"14","author":"Jiang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0200","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2204151","article-title":"Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge","volume":"12","author":"Zeng","year":"2023","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0205","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","article-title":"Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer","volume":"618","author":"Rojas","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0210","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(23)02268-7","article-title":"Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study","volume":"403","author":"Weber","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0215","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3390\/vaccines8040652","article-title":"Safety and immunogenicity of the GamTBvac, the recombinant subunit tuberculosis vaccine candidate: a phase II, multi-center, double-blind, randomized, placebo-controlled study","volume":"8","author":"Tkachuk","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0220","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1038\/s41467-021-26934-0","article-title":"A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Gu\u00e9rin","volume":"12","author":"Woodworth","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0225","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S2213-2600(20)30319-2","article-title":"Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial","volume":"9","author":"Day","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112811","article-title":"A multistage protein subunit vaccine as BCG-booster confers protection against Mycobacterium tuberculosis infection in murine models","volume":"139","author":"Chen","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114531","article-title":"Prediction of a novel synthetic peptide vaccine against tuberculosis and validation of its immunogenicity","volume":"153","author":"Zhang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002196","article-title":"What do we really know about how CD4 T cells control Mycobacterium tuberculosis?","volume":"7","author":"Torrado","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0245","article-title":"Splenic marginal zone B cells restrict Mycobacterium tuberculosis infection by shaping the cytokine pattern and cell-mediated immunity","volume":"43","author":"Sai","year":"2024","journal-title":"Cell Rep."},{"issue":"Suppl. 1","key":"10.1016\/j.ijbiomac.2025.150012_bb0250","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.tube.2011.10.016","article-title":"A defect in the synthesis of Interferon-\u03b3 by the T cells of complement-C5 deficient mice leads to enhanced susceptibility for tuberculosis","volume":"91","author":"Mashruwala","year":"2011","journal-title":"Tuberculosis (Edinb.)"},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0255","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fmicb.2014.00172","article-title":"Recombinant protein expression in Escherichia coli: advances and challenges","volume":"5","author":"Rosano","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0260","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1080\/07391102.2020.1844060","article-title":"Multi-epitope vaccine against SARS-CoV-2 applying immunoinformatics and molecular dynamics simulation approaches","volume":"40","author":"Jyotisha","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1269774","article-title":"Development of a multi-epitope vaccine candidate for leishmanial parasites applying immunoinformatics and in vitro approaches","volume":"14","author":"Jyotisha","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0270","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3390\/microorganisms11071647","article-title":"Design of a multi-epitope vaccine against tuberculosis from Mycobacterium tuberculosis PE_PGRS49 and PE_PGRS56 proteins by reverse vaccinology","volume":"11","author":"Ruaro-Moreno","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030839","article-title":"Synthetic Toll-like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants","volume":"7","author":"Shanmugam","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0280","doi-asserted-by":"crossref","first-page":"70","DOI":"10.32607\/20758251-2016-8-4-70-81","article-title":"Design of stable \u03b1-helical peptides and thermostable proteins in biotechnology and biomedicine","volume":"8","author":"Yakimov","year":"2016","journal-title":"Acta Nature"},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0285","doi-asserted-by":"crossref","first-page":"15923","DOI":"10.1038\/s41598-024-66858-5","article-title":"Immunoinformatics and structural aided approach to develop multi-epitope based subunit vaccine against Mycobacterium tuberculosis","volume":"14","author":"Sethi","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0290","doi-asserted-by":"crossref","first-page":"6874","DOI":"10.1016\/S0021-9258(19)39230-0","article-title":"Enhancement of the thermostability of subtilisin E by introduction of a disulfide bond engineered on the basis of structural comparison with a thermophilic serine protease","volume":"265","author":"Takagi","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0295","first-page":"246","article-title":"The role of TLR2 in infectious diseases caused by mycobacteria: from cell biology to therapeutic target","volume":"11","author":"Hu","year":"2022","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0300","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cellimm.2009.10.007","article-title":"Role of TLR2- and TLR4-mediated signaling in Mycobacterium tuberculosis-induced macrophage death","volume":"260","author":"S\u00e1nchez","year":"2010","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0305","doi-asserted-by":"crossref","first-page":"20961","DOI":"10.1074\/jbc.M411379200","article-title":"Mycobacterium tuberculosis heat shock proteins use diverse Toll-like receptor pathways to activate pro-inflammatory signals","volume":"280","author":"Bulut","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0310","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.tips.2022.12.005","article-title":"Computational and artificial intelligence-based methods for antibody development","volume":"44","author":"Kim","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109238","article-title":"Mycobacterium tuberculosis dormancy regulon proteins Rv2627c and Rv2628 as Toll-like receptor agonist and as potential adjuvant","volume":"112","author":"Bhatt","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0320","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s40203-025-00322-8","article-title":"In-silico development of a novel TLR2-mediating multi-epitope vaccine against Mycobacterium tuberculosis","volume":"13","author":"Singh","year":"2025","journal-title":"In Silico Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0325","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3389\/fimmu.2014.00491","article-title":"Macrophage cytokines: involvement in immunity and infectious diseases","volume":"5","author":"Arango Duque","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0330","article-title":"ESAT-6 protein of Mycobacterium tuberculosis inhibits differentiation of human monocytes to dendritic cells","author":"Manikoth","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0335","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.4049\/jimmunol.1501816","article-title":"Transduction of functionally contrasting signals by two mycobacterial PPE proteins downstream of TLR2 receptors","volume":"197","author":"Udgata","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.150012_bb0340","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nri3446","article-title":"The history of toll-like receptors - redefining innate immunity","volume":"13","author":"O\u2019Neill","year":"2013","journal-title":"Nat. Rev. Immunol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025105692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025105692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:37:44Z","timestamp":1777484264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025105692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":68,"alternative-id":["S0141813025105692"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.150012","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting mycobacterial PPE65 protein to develop a multi-epitope vaccine candidate against tuberculosis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.150012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150012"}}